| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 83386 |
CAS: 2353409-82-0,Gly-Gly-Gly-PEG4-Methyltetrazine |
155 |
WYQ |
2024-12-20 |
| 83387 |
cas:120042-14-0,L-Azidohomoalanine,2(S)-氨基-4-叠氮基丁酸 |
112 |
kx |
2024-12-20 |
| 83388 |
Thiol-((CH2))11-PEG6-OH |
127 |
h |
2024-12-20 |
| 83389 |
CAS: 170941-79-4,Fmoc-Gly-Gly-Gly-OH |
173 |
WYQ |
2024-12-20 |
| 83390 |
Glucose Gold Nanoparticle Liposomes,葡萄糖金纳米颗粒脂质体 |
182 |
axc |
2024-12-20 |
| 83391 |
DBCO-NH-(CH2)4COOH,CAS:2375193-74-9 |
135 |
h |
2024-12-20 |
| 83392 |
CAS: 28320-73-2,Boc-Gly-Gly-Gly-OH |
165 |
WYQ |
2024-12-20 |
| 83393 |
cas:29248-48-4,Glycine, N-[(1,1-dimethylethoxy)carbonyl]glycyl-, 2,5-dioxo-1-pyrrolidinyl ester, ADC试剂 |
114 |
kx |
2024-12-20 |
| 83394 |
cas:2504147-59-3 MC (C5)-Val-Cit的介绍 |
129 |
zyl |
2024-12-20 |
| 83395 |
DBCO-C6-acid,1425485-72-8 |
140 |
h |
2024-12-20 |
| 83396 |
PEGylated Gold Nanoparticle Liposomes,聚乙二醇化金纳米粒子脂质体 |
161 |
axc |
2024-12-20 |
| 83397 |
Fmoc-Ala-Ser (Psi(Me,Me)pro)-OH,CAS号:252554-78-21 |
187 |
WYQ |
2024-12-20 |
| 83398 |
CH3(CH2)8CO-QRIWQRIQ-amide |
173 |
h |
2024-12-20 |
| 83399 |
cas:79642-50-5,DSG Crosslinker,双琥珀酰亚胺戊二酸酯 |
111 |
kx |
2024-12-20 |
| 83400 |
Fmoc-Ala-Pro-OH ,芴甲氧羰基-β-丙氨酰-L-脯氨酸 |
141 |
WYQ |
2024-12-20 |
| 83401 |
Spherical Gold Nanoparticle Liposomes,球形金纳米颗粒脂质体 |
156 |
axc |
2024-12-20 |
| 83402 |
Fmoc-NH-pentoic acid-NHS-SO3Na,抗体药物偶联物(ADC) |
166 |
kx |
2024-12-20 |
| 83403 |
Liposomal-gold Nanoparticles 脂质体金纳米粒子 |
206 |
axc |
2024-12-20 |
| 83404 |
cas:870487-09-5 Boc-Val-Cit-PAB |
146 |
zyl |
2024-12-20 |
| 83405 |
Biotin-PEG12-Gly-Gly-Gly ,生物素聚乙二醇甘氨酸 |
105 |
WYQ |
2024-12-20 |
| 83406 |
HOCO(CH2)16 |
194 |
h |
2024-12-20 |
| 83407 |
Phosphatidic Acid (PA),磷酸(PA) |
354 |
axc |
2024-12-20 |
| 83408 |
cas:159857-79-1 Val-Cit-PAB-OH的结构式 |
228 |
zyl |
2024-12-20 |
| 83409 |
cas:367927-39-7,SMPH Crosslinker,琥珀酰亚胺基6-[(3-马来酰亚胺基)丙酰胺基]-己酸酯 |
150 |
kx |
2024-12-20 |
| 83410 |
cas:870487-08-4,Boc-Val-Cit |
152 |
zyl |
2024-12-20 |
| 83411 |
alpha-GalNAc-TEG-Alkyne,丙-2-炔氧基乙氧基)乙氧基)乙氧基)-2-乙酰氨基-2脱氧-α-D-吡喃半乳糖苷 |
236 |
wyh |
2024-12-20 |
| 83412 |
cas:99208-90-9,Alkynyl Palmitic Acid,15-十六碳炔酸 |
138 |
kx |
2024-12-20 |
| 83413 |
Mal-amido-PEG8-Val-Gly-PAB-OH(CAS号:2353409-52-4) |
142 |
WYQ |
2024-12-20 |
| 83414 |
MC-Gly-Gly-Phe-Gly 一种可降解 (cleavable) 的 ADC linker |
235 |
zyl |
2024-12-20 |
| 83415 |
Azido-PEG10-CH2COOH |
117 |
wyh |
2024-12-20 |
| 83416 |
Mal-amido-PEG8-Val-Gly(CAS号:2353409-54-6) |
121 |
WYQ |
2024-12-20 |
| 83417 |
Alloc-Val-Ala-PAB-PNP(CAS号:1884578-27-1) |
165 |
WYQ |
2024-12-20 |
| 83418 |
Sulfhydryl Reactive Liposomes,巯基反应脂质体 |
151 |
axc |
2024-12-20 |
| 83419 |
cas:100462-73-5,diethyl 7-bromoheptylphosphonate,7-溴庚基二膦酸二乙酯 |
150 |
kx |
2024-12-20 |
| 83420 |
Propargyl-PEG2-CH2COOH,丙炔基-二聚乙二醇-乙酸 |
147 |
wyh |
2024-12-20 |
| 83421 |
Mal-amido-PEG8-val-gly-PAB-OH - CAS 2353409-52-4 |
139 |
zyl |
2024-12-20 |
| 83422 |
DBCO-PEG4-Val-Ala-PAB-PNP,CAS号:2348405-93-4 |
151 |
WYQ |
2024-12-20 |
| 83423 |
Metal Chelating Liposomes,金属螯合脂质体 |
156 |
axc |
2024-12-20 |
| 83424 |
HS-PEG10-CH2CH2COOH,硫基十聚乙二醇丙酸 |
305 |
wyh |
2024-12-20 |
| 83425 |
cas:1446282-24-1,[10-(Diethoxy-phosphoryl)-decyl]-phosphonic acid,抗体药物偶联物(ADC) |
209 |
kx |
2024-12-20 |
| 83426 |
Folate Liposomes,叶酸脂质体 |
197 |
axc |
2024-12-20 |
| 83427 |
MC-Val-Cit-Doxorubicin ,CAS号:159857-70-2 |
154 |
WYQ |
2024-12-20 |
| 83428 |
alpha-GalNAc-TEG-Alkyne,丙-2-炔氧基乙氧基)乙氧基)乙氧基)-2-乙酰氨基-2脱氧-α-D-吡喃半乳糖苷 |
195 |
wyh |
2024-12-20 |
| 83429 |
Azido-PEG4-Val-Ala-PAB的结构式 |
197 |
zyl |
2024-12-20 |
| 83430 |
cas:5943-17-9,Tetraethyl heptane-1,7-diylbis(phosphonate), ADC试剂 |
126 |
kx |
2024-12-20 |